000 | 01182 a2200301 4500 | ||
---|---|---|---|
005 | 20250513034350.0 | ||
264 | 0 | _c19950830 | |
008 | 199508s 0 0 eng d | ||
022 | _a0268-1315 | ||
024 | 7 |
_a10.1097/00004850-199503000-00002 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aStein, D J | |
245 | 0 | 0 |
_aMeta-analysis of pharmacotherapy trials for obsessive-compulsive disorder. _h[electronic resource] |
260 |
_bInternational clinical psychopharmacology _cMar 1995 |
||
300 |
_a11-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Meta-Analysis | ||
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aObsessive-Compulsive Disorder _xdrug therapy |
650 | 0 | 4 | _aPsychiatric Status Rating Scales |
650 | 0 | 4 |
_aPsychotropic Drugs _xadministration & dosage |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 |
_aSelective Serotonin Reuptake Inhibitors _xtherapeutic use |
700 | 1 | _aSpadaccini, E | |
700 | 1 | _aHollander, E | |
773 | 0 |
_tInternational clinical psychopharmacology _gvol. 10 _gno. 1 _gp. 11-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00004850-199503000-00002 _zAvailable from publisher's website |
999 |
_c7622237 _d7622237 |